Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 2 analysts offering 12 month price targets for Shanghai Henlius Biotech Inc have a median target of 22.49, with a high estimate of 24.63 and a low estimate of 20.36. The median estimate represents a 11.04% increase from the last price of 20.25.
High | 21.6% | 24.63 |
Med | 11.0% | 22.49 |
Low | 0.5% | 20.36 |
Earnings history & estimates in CNY
Average growth rate | +8.63% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +222.86% |
More ▼